Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: neuroscience – Page 681

Scientists explain emotional ‘blunting’ caused by common antidepressants

Scientists have worked out why common anti-depressants cause around half of users to feel emotionally “blunted.” In a study published today in Neuropsychopharmacology, they show that the drugs affect reinforcement learning, an important behavioral process that allows people to learn from their environment.

According to the NHS, more than 8.3 million patients in England received an in 2021/22. A widely used class of antidepressants, particularly for persistent or severe cases, is (SSRIs). These drugs target serotonin, a chemical that carries messages between in the brain and has been dubbed the “pleasure chemical.”

One of the widely reported side effects of SSRIs is “blunting,” where patients report feeling emotionally dull and no longer finding things as pleasurable as they used to. Between 40% and 60% of patients taking SSRIs are believed to experience this side effect.

VALL-E

Chengyi wang*, sanyuan chen*, yu wu*, ziqiang zhang, long zhou, shujie liu, zhuo chen, yanqing liu, huaming wang, jinyu li, lei he, sheng zhao, furu wei.

Microsoft

Abstract. We introduce a language modeling approach for text to speech synthesis (TTS). Specifically, we train a neural codec language model (called VALL-E) using discrete codes derived from an off-the-shelf neural audio codec model, and regard TTS as a conditional language modeling task rather than continuous signal regression as in previous work. During the pre-training stage, we scale up the TTS training data to 60K hours of English speech which is hundreds of times larger than existing systems. VALL-E emerges in-context learning capabilities and can be used to synthesize high-quality personalized speech with only a 3-second enrolled recording of an unseen speaker as an acoustic prompt. Experiment results show that VALL-E significantly outperforms the state-of-the-art zero-shot TTS system in terms of speech naturalness and speaker similarity. In addition, we find VALL-E could preserve the speaker’s emotion and acoustic environment of the acoustic prompt in synthesis.

‘Partly Alive’: Scientists Revive Cells in Brains From Dead Pigs

Year 2019 face_with_colon_three

In a study that raises profound questions about the line between life and death, researchers have restored some cellular activity to brains removed from slaughtered pigs.

The brains did not regain anything resembling consciousness: There were no signs indicating coordinated electrical signaling, necessary for higher functions like awareness and intelligence.

But in an experimental treatment, blood vessels in the pigs’ brains began functioning, flowing with a blood substitute, and certain brain cells regained metabolic activity, even responding to drugs. When the researchers tested slices of treated brain tissue, they discovered electrical activity in some neurons.

Study examines brain aging in people with schizophrenia

People suffering from schizophrenia can expect to die 15 years sooner than they ordinarily would. A new study has now found that this could be partly caused by advanced brain aging. The research findings were published in the journal Molecular Psychiatry.

Schizophrenia is associated with an increased risk of premature death, partially as a result of suicide or poor physical health. Studies to date have suggested that the high prevalence of disease, long-term and excess deaths in people with schizophrenia could in part be caused when their brain’s biological age overtakes the .

According to a few small-scale studies, this discrepancy called brain-predicted age difference (brain-PAD) has been found to be consistently higher in schizophrenic patients compared to healthy individuals. The studies have also shown that the gap between the two ages mainly widens during the first years after the onset of the illness.

Promising Parkinson’s Disease Treatment Candidate Identified in Mouse Study

A new study has identified a promising drug candidate that can protect neurons from degeneration in mouse models of Parkinson’s disease. The research is published in Science Translational Medicine.

Addressing an unmet need

Parkinson’s disease (PD) is the second most common neurodegenerative disease, and over the last 25 years, the prevalence of PD has doubled, presenting a large health burden across the globe.

New Nanoparticles Deliver Therapy Brain-Wide and Edit Alzheimer’s Gene

Summary: Researchers have developed a new family of nano-scale capsules capable of carrying CRISPR gene editing tools to different organs of the body before harmlessly dissolving. The capsules were able to enter the brains of mice and successfully edit a gene associated with Alzheimer’s disease.

Source: University of Wisconsin-Madison.

Gene therapies have the potential to treat neurological disorders like Alzheimer’s and Parkinson’s diseases, but they face a common barrier — the blood-brain barrier.

Cancer-selective chemotherapy using a disassembly-assembly method

Dual-action cell therapy engineered to eliminate established tumors and train the immune system to eradicate primary tumor and prevent cancer’s recurrence. Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, investigators have developed a new cell therapy approach to eliminate established tumors and induce long-term immunity, training the immune system so that it can prevent cancer from recurring. The team tested their dual-action, cancer-killing vaccine in an advanced mouse model of the deadly brain cancer glioblastoma, with promising results. Findings are published in Science Translational Medicine.

A New Field of Neuroscience Aims to Map Connections in the Brain

Many of us have seen microscopic images of neurons in the brain — each neuron appearing as a glowing cell in a vast sea of blackness. This image is misleading: Neurons don’t exist in isolation. In the human brain, some 86 billion neurons form 100 trillion connections to each other — numbers that, ironically, are far too large for the human brain to fathom.

Wei-Chung Allen Lee, Harvard Medical School associate professor of neurology at Boston Children’s Hospital, is working in a new field of neuroscience called connectomics, which aims to comprehensively map connections between neurons in the brain.

Study shows how iron dysregulation might contribute to neurodegenerative diseases

Past neuroscience research consistently found a link between deviations from the “normal” iron metabolism, also known as iron dysregulation, and different neurodegenerative diseases, including Parkinson’s disease (PD) and Multiple Sclerosis (MS). Specifically, brain regions associated with these diseases have been found to be often populated by microglia (i.e., resident immune cells) packed with Iron.

While the association between iron dysregulation and neurodegenerative diseases is well documented, the ways in which iron accumulation affects the physiology of and neurodegeneration are yet to be fully grasped. Researchers at global health care company Sanofi have recently carried out a study aimed at filling this gap in the literature, by better understanding how microglia respond to iron.

“For years it has been known that iron accumulates in affected in PD, MS and other neurodegenerative diseases,” Timothy Hammond, one of the researchers who carried out the study, told MedicalXpress. “This is something we can see in patients using MRI imaging, where it has been shown that iron levels increase over the course of the disease. We also had our own data from progressive MS patients showing iron dysregulation in brain microglia, the resident immune cells of the brain.”

/* */